Massive study aims to decode metabolic syndrome using Cutting-Edge science
NCT ID NCT07248371
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is collecting and analyzing genetic, metabolic, and microbiome data from over 6,000 people with and without metabolic syndrome. The goal is to find biological markers that predict disease progression and help create personalized prevention and treatment plans. Participants must be 20 or older and cannot have certain conditions like end-stage kidney disease or active cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES (CVD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chang Gung Memorial Hospitals, Linkou
RECRUITINGTaoyuan, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Aging kidneys under the microscope: could a simple test predict failure?
- Could everyday disinfectants be harming us? a new study investigates